终末期肝病食谱应用程序联合人工肝治疗肝衰竭合并营养不良患者的效果

张萌 ,  王晶

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (9) : 858 -861.

PDF (397KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (9) : 858 -861. DOI: 10.12007/j.issn.0258‐4646.2026.09.016
短篇论著

终末期肝病食谱应用程序联合人工肝治疗肝衰竭合并营养不良患者的效果

作者信息 +

Effect of the end-stage liver disease recipe application combined with artificial liver therapy in liver failure patients complicated with malnutrition

Author information +
文章历史 +
PDF (405K)

摘要

本文旨在探讨终末期肝病食谱应用程序 (ESLDR APP) 联合人工肝治疗对肝衰竭合并营养不良患者的临床疗效。结果显示,与治疗前相比,使用ESLDR APP治疗3个周期的肝衰竭患者,蛋白水平升高、肝功能损伤程度减轻。ESLDR APP为患者制定的科学营养食谱联合人工肝支持治疗系统,可以帮助患者提升蛋白水平、改善营养状况并纠正氨基酸代谢紊乱,为临床综合治疗提供参考。

关键词

肝衰竭 / 人工肝 / 营养不良 / 代谢组学 / 终末期肝病食谱应用程序

Key words

引用本文

引用格式 ▾
张萌,王晶. 终末期肝病食谱应用程序联合人工肝治疗肝衰竭合并营养不良患者的效果[J]. 中国医科大学学报, 2026, 55(9): 858-861 DOI:10.12007/j.issn.0258‐4646.2026.09.016

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

XUE R,DUAN ZH,LIU HX,et al. A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on- chronic liver failure [J]. Oncotarget,2017,8 (65):108970-108980. DOI:10.18632/oncotarget.22447.

[2]

SINGH T,GUPTA N,ALKHOURI N,et al. A guide to managing acute liver failure [J]. Clevel Clin J Med,2016,83 (6):453-462. DOI:10.3949/ccjm.83a.15101.

[3]

韩涛. 《肝衰竭诊治指南 (2024年版) 》解读 [J]. 临床肝胆病杂志,2024,40 (12):2388-2391. DOI:10.12449/JCH241207.

[4]

LIU X,KONG M,HUA X,et al. Effects of an individualized nutrition intervention on the respiratory quotient of patients with liver failure [J]. Asia Pac J Clin Nutr,2019,28 (3):428-434. DOI:10.6133/apjcn.201909_28(3).0001.

[5]

YAO J,ZHOU XS,WANG H,et al. Persistently increased resting energy expenditure predicts short-term mortality in patients with acute- on-chronic liver failure [J]. Ann Nutr Metab,2018,73 (1):2-9. DOI:10.1159/000487604.

[6]

MENG QH,HOU W,YU HW,et al. Resting energy expenditure and substrate metabolism in patients with acute-on-chronic hepatitis B liver failure [J]. J Clin Gastroenterol,2011,45 (5):456-461. DOI:10.1097/MCG.0b013e31820f7f02.

[7]

蓝婧. 双重血浆分子吸附系统治疗肝衰竭的研究进展 [J]. 慢性病杂志,2024,25 (3):357-359,363. DOI:10.16440/J.CNKI.1674-8166.2024.03.08

[8]

KELL DB. Metabolomics,modelling and machine learning in systems biology-towards an understanding of the languages of cells:delivered on 3 July 2005 at the 30th FEBS Congress and 9th IUBMB conference in Budapest [J]. FEBS J,2006,273 (5):873-894. DOI:10.1111/j.1742-4658.2006.05136.x.

[9]

FIEHN O. Metabolomics-the link between genotypes and pheno types [J]. Plant Mol Biol,2002,48 (1/2):155-171. DOI:10.1023/a:1013713905833.

[10]

GOODACRE R,VAIDYANATHAN S,DUNN WB,et al. Metabo lomics by numbers:acquiring and understanding global metabolite data [J]. Trends Biotechnol,2004,22 (5):245-252. DOI:10.1016/j.tibtech.2004.03.007.

[11]

HUANG SP,HU DL,YUAN SS,et al. The serum metabolomics study of liver failure and artificial liver therapy intervention [J]. Med Sci Monit,2021,27:e930638. DOI:10.12659/msm.930638.

[12]

GRIFFIN JL. The Cinderella story of metabolic profiling:does me tabolomics get to go to the functional genomics ball [J]. Phil Trans R Soc B,2006,361 (1465):147-161. DOI:10.1098/rstb.2005.1734.

[13]

胡大利. 肝衰竭和人工肝治疗干预的血液代谢组学研究[D]. 南 昌:南昌大学,2020.

[14]

余立平,张强,黄亚娜,等. 两种方法评估肝硬化病人营养状况及其与肌肉减少症的关联性 [J]. 安徽医药,2023,27 (8):1624-1628. DOI:10.3969/j.issn.1009-6469.2023.08.029.

[15]

段钟平,杨云生. 终末期肝病临床营养指南 [J]. 实用肝脏病杂 志,2019,22 (5):624-635. DOI:10.3969/j.issn.1672-5069.2019.05.005.

[16]

郭艳,唐中权. 肝硬化营养不良检测手段与评估工具应用进展[J/ OL]. 中国肝脏病杂志 (电子版),2020,12 (1):1-5. DOI:10.3969/j.issn.1674-7380.2020.01.001.

基金资助

内蒙古公立医院科研联合基金科技项目(2023GLLH0208)

AI Summary AI Mindmap
PDF (397KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉